<p>(<b>A</b>) Tat augments vIL-6-induced phosphorylation of AKT and GSK-3β in nude mice. Phosphorylation AKT and GSK-3β in tumor tissues from 4E3 and T/V cells transduced by Tat and Mock in nude mice were analyzed by Western blot. (<b>B</b>) Plot of the volume of the tumors. 4E3 cells were transfected by the AKT-DN and its control plasmid pSRα for 24 hours and followed by Tat or Mock transduction for another 24 hours. Cells were injected s.c. into the left flank of the mice. The animals were monitored every day for the appearance of tumors until 30 days. Tumor size was estimated by two-dimensional caliper measurement. The results are expressed as the mean ± SD (n = 5). *<i>P</i><.05 and **<i>P</i><.01 for Student’s <i>t</i>-test versus Tat+...
<p>(A) BALB/c-nu mice were injected subcutaneously with 1×10<sup>7</sup> of U251, U251-neo, or U251-...
We explore mechanisms that enable cancer cells to tolerate PI3K or Akt inhibitors. Prolonged treatme...
Using a model of medroxyprogesterone acetate (MPA)-induced mouse mammary tumors that transit through...
<p>(<b>A</b>) Plot of the volume of the tumors. 4E3 and T/V cells were transduced by Tat, △Tat or Mo...
<p>(<b>A</b>) Inhibition of PI3K activity suppressed the enhanced effect of Tat on vIL-6-mediated an...
<p>(<b>A</b>) Effects of Tat on vIL-6 promoter activities in 293T cells. Cells were transfected with...
<p>(<b>A</b>) Overexpression of PTEN suppressed the enhanced effect of Tat on vIL-6-mediated angioge...
<p>(<b>A–B</b>) Nude mice bearing subcutaneous, MDA-MB-231 xenographic tumors were injected with the...
Elevated expression of AKT has been noted in a significant percentage of primary human breast cancer...
© 2014 Carnero and Paramio. When PI3K (phosphatidylinositol 3 kinase) is activated by receptor tyros...
SummaryThe downstream effector of PI3K, Akt, is frequently hyperactivated in human cancers. A critic...
PTEN is mutated at high frequency in many primary human cancers and several familial cancer predispo...
We explore mechanisms that enable cancer cells to tolerate PI3K or Akt inhibitors. prolonged treatme...
<p>(A) PI3K expression increases with malignant progression. Representative immunohistochemical stai...
<p>AKT2,3 and AKT1,3 double knockdown cells as well as control cells were injected subcutaneously in...
<p>(A) BALB/c-nu mice were injected subcutaneously with 1×10<sup>7</sup> of U251, U251-neo, or U251-...
We explore mechanisms that enable cancer cells to tolerate PI3K or Akt inhibitors. Prolonged treatme...
Using a model of medroxyprogesterone acetate (MPA)-induced mouse mammary tumors that transit through...
<p>(<b>A</b>) Plot of the volume of the tumors. 4E3 and T/V cells were transduced by Tat, △Tat or Mo...
<p>(<b>A</b>) Inhibition of PI3K activity suppressed the enhanced effect of Tat on vIL-6-mediated an...
<p>(<b>A</b>) Effects of Tat on vIL-6 promoter activities in 293T cells. Cells were transfected with...
<p>(<b>A</b>) Overexpression of PTEN suppressed the enhanced effect of Tat on vIL-6-mediated angioge...
<p>(<b>A–B</b>) Nude mice bearing subcutaneous, MDA-MB-231 xenographic tumors were injected with the...
Elevated expression of AKT has been noted in a significant percentage of primary human breast cancer...
© 2014 Carnero and Paramio. When PI3K (phosphatidylinositol 3 kinase) is activated by receptor tyros...
SummaryThe downstream effector of PI3K, Akt, is frequently hyperactivated in human cancers. A critic...
PTEN is mutated at high frequency in many primary human cancers and several familial cancer predispo...
We explore mechanisms that enable cancer cells to tolerate PI3K or Akt inhibitors. prolonged treatme...
<p>(A) PI3K expression increases with malignant progression. Representative immunohistochemical stai...
<p>AKT2,3 and AKT1,3 double knockdown cells as well as control cells were injected subcutaneously in...
<p>(A) BALB/c-nu mice were injected subcutaneously with 1×10<sup>7</sup> of U251, U251-neo, or U251-...
We explore mechanisms that enable cancer cells to tolerate PI3K or Akt inhibitors. Prolonged treatme...
Using a model of medroxyprogesterone acetate (MPA)-induced mouse mammary tumors that transit through...